Research graph
References from Receptor transporter protein 4 (RTP4)-mediated repression of hepatitis C virus replication in mouse cells. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1099/jgv.0.000672
10.1099/jgv.0.000672 · 2017 · External reference
Regional progress towards hepatitis C elimination in the Western Pacific Region, 2015-2020
10.35772/ghm.2021.01065 · 2021 · External reference
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
10.1016/s2468-1253(16)30181-9 · 2017 · External reference
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
10.1016/j.jhep.2006.05.013 · 2006 · External reference
Global Elimination of Chronic Hepatitis
10.1056/nejmra1810477 · 2019 · External reference
Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection
10.1038/s41590-020-00817-w · 2021 · External reference
The Strange, Expanding World of Animal Hepaciviruses
10.1146/annurev-virology-100114-055104 · 2016 · External reference
Barriers to hepatitis C virus infection in mice
10.1016/j.coviro.2022.101273 · 2022 · External reference
Animal studies. NIH to end chimp breeding for research
10.1126/science.316.5829.1265 · 2007 · External reference
Ethics of Controlled Human Infection Studies With Hepatitis C Virus
2023 · External reference
Animal Models Used in Hepatitis C Virus Research
10.3390/ijms21113869 · 2020 · External reference
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice
2020 · External reference
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
10.1038/nature07684 · 2009 · External reference
TRIM26 is a critical host factor for HCV replication and contributes to host tropism
10.1126/sciadv.abd9732 · 2021 · External reference
Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus
10.7554/elife.44436 · 2019 · External reference
Mouse hepatic cells support assembly of infectious hepatitis C virus particles
10.1053/j.gastro.2011.06.010 · 2011 · External reference
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
10.1038/nature12427 · 2013 · External reference
RTP4 Is a Potent IFN-Inducible Anti-flavivirus Effector Engaged in a Host-Virus Arms Race in Bats and Other Mammals
2020 · External reference
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
10.1073/pnas.0504877103 · 2006 · External reference
Inflammatory stimulation upregulates the receptor transporter protein 4 (RTP4) in SIM-A9 microglial cells
10.3390/ijms252413676 · 2024 · External reference
Accurate structure prediction of biomolecular interactions with AlphaFold 3
10.1038/s41586-024-07487-w · 2024 · External reference
UCSF ChimeraX: Tools for structure building and analysis
2023 · External reference
ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation
10.1093/nar/gkz863 · 2019 · External reference
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication
10.1128/jvi.76.24.13001-13014.2002 · 2002 · External reference
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A
10.1002/hep.24542 · 2011 · External reference
Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms
10.1038/srep07242 · 2014 · External reference
Innate immunity against hepatitis C virus
10.1016/j.coi.2016.06.009 · 2016 · External reference
RTP4 restricts influenza A virus infection by targeting the viral NS1 protein
10.1016/j.virol.2025.110397 · 2025 · External reference
Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4)
2023 · External reference
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
10.1073/pnas.2006492117 · 2020 · External reference
Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo
10.1128/jvi.01799-16 · 2017 · External reference
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
10.1126/scitranslmed.3009512 · 2014 · External reference
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
10.1172/jci40094 · 2010 · External reference
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation
10.1002/hep.27913 · 2015 · External reference
Hepatitis C Viral Replication Complex
10.3390/v13030520 · 2021 · External reference
Receptor Transporter Protein 4 (RTP4) in the Hypothalamus Is Involved in the Development of Antinociceptive Tolerance to Morphine
10.3390/biom12101471 · 2022 · External reference
Regulation of an Opioid Receptor Chaperone Protein, RTP4, by Morphine
10.1124/mol.118.112987 · 2019 · External reference
Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4
10.1073/pnas.0804106105 · 2008 · External reference
RTP4 is a novel prognosis-related hub gene in cutaneous melanoma
10.1186/s41065-021-00183-z · 2021 · External reference
Genetic variants at the RTP4/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sjögren’s syndrome
10.1136/rmdopen-2021-001832 · 2021 · External reference
Bioinformatic Analysis Identifies Biomarkers and Treatment Targets in Primary Sjögren’s Syndrome Patients with Fatigue
10.1155/2022/7697558 · 2022 · External reference
Functional-genomic analysis reveals intraspecies diversification of antiviral receptor transporter proteins in Xenopus laevis
2021 · External reference
Identification of rodent homologs of hepatitis C virus and pegiviruses
10.1128/mbio.00216-13 · 2013 · External reference
Evidence for novel hepaciviruses in rodents
10.1371/journal.ppat.1003438 · 2013 · External reference
Functional role of type I and type II interferons in antiviral defense
10.1126/science.8009221 · 1994 · External reference
Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier
10.1038/ni1132 · 2004 · External reference
Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons
10.1128/jvi.03129-14 · 2015 · External reference
Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV)
2011 · External reference
Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms
10.1053/j.gastro.2013.08.037 · 2013 · External reference
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
10.1016/j.virol.2013.05.036 · 2013 · External reference
Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities
10.1128/jvi.00586-06 · 2006 · External reference
Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122
10.1128/jvi.00559-10 · 2010 · External reference
A diverse range of gene products are effectors of the type I interferon antiviral response
10.1038/nature09907 · 2011 · External reference
The continued threat of emerging flaviviruses
10.1038/s41564-020-0714-0 · 2020 · External reference
What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats
10.1053/j.gastro.2018.10.048 · 2019 · External reference
Controlled human infection model - fast track to HCV vaccine?
10.1056/nejmsb2109093 · 2021 · External reference
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real
2023 · External reference
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations
2023 · External reference
Complete replication of hepatitis C virus in cell culture
10.1126/science.1114016 · 2005 · External reference
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns
2018 · External reference
Tools for integrated sequence-structure analysis with UCSF Chimera
10.1186/1471-2105-7-339 · 2006 · External reference
10.1073/pnas.0503596102
10.1073/pnas.0503596102 · 2005 · External reference
A simple method of estimating fifty per cent endpoints
10.1093/oxfordjournals.aje.a118408 · 1938 · External reference
BRB-seq: ultra-affordable high-throughput transcriptomics enabled by bulk RNA barcoding and sequencing
10.1186/s13059-019-1671-x · 2019 · External reference
Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors
10.1126/scisignal.adf5494 · 2023 · External reference
Tn5 transposase and tagmentation procedures for massively scaled sequencing projects
10.1101/gr.177881.114 · 2014 · External reference
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
10.1186/s13059-014-0550-8 · 2014 · External reference
Unresolved reference
External reference
In situ detection of protein-protein interaction by proximity ligation assay in patient derived brain tumor stem cells
10.1016/j.xpro.2022.101554 · 2022 · External reference
A Threshold Selection Method from Gray-Level Histograms
10.1109/tsmc.1979.4310076 · 1979 · External reference
Generation of Human Liver Chimeric Mice for the Study of Human Hepatotropic Pathogens
10.1007/978-1-4939-3661-8_5 · 2016 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
